BioIntelliSense, a continuous health monitoring and clinical intelligence company, has entered into a strategic collaboration with Renown Health, a not-for-profit integrated healthcare network of hospitals and care facilities serving over one million people in Nevada and northeast California. The partnership provides more convenient, effective and personalized care to patients via continuous remote monitoring for both in-hospital patient care as well as at-home health management. This program integrates BioIntelliSense’s FDA-cleared BioSticker™ wearable device into Renown Health’s clinical remote monitoring services to address today’s healthcare workforce shortage challenges and enhance a patient-centered model of care. Read more.
Related Posts
Penn Medicine Forms Joint Venture with Evergreen Nephrology for Kidney Disease Patients
The joint venture – a 50/50 partnership between UPHS and Evergreen – contracts with the Centers for Medicare and Medicaid Services to provide care for Medicare patients with kidney disease, including those receiving dialysis.
March 14, 2022
Vantage Health and Gramercy Surgery Center Announces Equity Partnership
The two award-winning healthcare providers joined forces to strengthen the comprehensive care model and improve access to affordable, high-quality surgical and cancer care.
July 23, 2021
Summus Global to Collaborate with Boston Children’s Hospital on Pediatric Telehealth
Virtual specialist platform Summus Global announced a collaboration with Boston Children's Hospital as part of their work in technology and virtual care for families around the world. Through this new collaboration, Summus will work with the innovation team and physician faculty at Boston Children's to support ways to scale specialist expertise to reach more patients and families around the world.
May 5, 2022
Ivy Rehab Partners with Maximum Performance Physical Therapy and Sports Rehabilitation of New Jersey
Founded in 2003, the Ivy Rehab Network is comprised of multiple brands and is backed by middle-market private equity firm Waud Capital Partners.
December 21, 2022